(VIANEWS) – Himax Technologies (HIMX), Eli Lilly and Company (LLY), Northrim BanCorp (NRIM) are the highest payout ratio stocks on this list.
We have congregated information regarding stocks with the highest payout ratio as yet. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. Himax Technologies (HIMX)
125.33% Payout Ratio
Himax Technologies, Inc., a fabless semiconductor company, provides display imaging processing technologies in China, Taiwan, the Philippines, Korea, Japan, Europe, and the United States. The company operates through two segments, Driver IC and Non-Driver Products. It offers display driver integrated circuits (ICs) and timing controllers that are used in televisions, laptops, monitors, mobile phones, tablets, automotive, digital cameras, car navigation, virtual reality devices, and other consumer electronic devices. The company also designs and provides controllers for touch sensor displays; in-cell touch and display driver integration single-chip solutions; light-emitting diode driver and power management ICs; and liquid crystal on silicon micro-displays for augmented reality (AR) devices and head-up displays for automotive industry. In addition, it offers complementary metal oxide semiconductor image sensors and wafer level optics for AR devices, 3D sensing, machine vision, and ultra-low power smart sensing, which are used in various applications, such as mobile phone, tablet, laptop, TV, PC camera, automobile, security, medical devices, home appliance, and Internet of Things. The company markets its display drivers and display-related products to panel manufacturers, agents or distributors, module manufacturers, and assembly houses; and non-driver products to camera module manufacturers, optical engine manufacturers, and television system manufacturers. Himax Technologies, Inc. was founded in 2001 and is headquartered in Tainan City, Taiwan.
Earnings Per Share
As for profitability, Himax Technologies has a trailing twelve months EPS of $0.38.
PE Ratio
Himax Technologies has a trailing twelve months price to earnings ratio of 16.47. Meaning, the purchaser of the share is investing $16.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.84%.
Yearly Top and Bottom Value
Himax Technologies’s stock is valued at $6.26 at 02:23 EST, way below its 52-week high of $8.70 and way higher than its 52-week low of $4.81.
Sales Growth
Himax Technologies’s sales growth for the next quarter is negative 2.3%.
2. Eli Lilly and Company (LLY)
58.77% Payout Ratio
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $6.3.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 83.82. Meaning, the purchaser of the share is investing $83.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 65.6%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 49.5% and 52.2%, respectively.
3. Northrim BanCorp (NRIM)
43.48% Payout Ratio
Northrim BanCorp, Inc. operates as the bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals. It operates in two segments, Community Banking and Home Mortgage Lending. The company offers noninterest-bearing checking accounts and interest-bearing time deposits, checking and savings accounts, individual retirement accounts, money market deposit accounts, and certificates of deposit. It also provides family residential mortgages; commercial loans, such as secured and unsecured loans for working capital and expansion; commercial real estate loans; construction loans for commercial real estate projects, and land development and residential subdivision construction loans; and loans for automobiles, recreational vehicles, boats, and other consumer purchases, as well as home equity and commercial credit lines, and factoring services. In addition, the company offers other services that include consumer online banking, mobile app and mobile deposit, mobile Web and text banking, business online banking, personal finance, online documents, consumer and business debit cards, home equity advantage access cards, and telebanking and automated teller services. Further, it provides personalized checks, overdraft protection from savings accounts, commercial drive-up banking, automatic transfers and payments, people pay, external and wire transfers, bill pay, direct payroll deposits, electronic tax payments, automated clearing house origination and receipt, remote deposit capture, and account reconciliation and positive pay services, as well as merchant and cash management programs, annuity products, and long term investment portfolios. As of December 31, 2020, the company operated 16 branches in Anchorage, the Matanuska-Susitna Valley, Juneau, Fairbanks, Ketchikan, Sitka, and Kenai Peninsula. Northrim BanCorp, Inc. was founded in 1990 and is headquartered in Anchorage, Alaska.
Earnings Per Share
As for profitability, Northrim BanCorp has a trailing twelve months EPS of $4.91.
PE Ratio
Northrim BanCorp has a trailing twelve months price to earnings ratio of 10.05. Meaning, the purchaser of the share is investing $10.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.34%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.9%, now sitting on 127.81M for the twelve trailing months.
Sales Growth
Northrim BanCorp’s sales growth is negative 3.1% for the ongoing quarter and negative 6.9% for the next.
4. Ark Restaurants Corp. (ARKR)
39.34% Payout Ratio
Ark Restaurants Corp., through its subsidiaries, owns and operates restaurants and bars in the United States. As of December 19, 2022, it owned and operated 17 restaurants and bars, including four restaurants located in New York City; one in Washington, D.C.; five in Las Vegas, Nevada; one in Atlantic City, New Jersey; four on the east coast of Florida; and two on the gulf coast of Alabama, as well as had 16 fast food concepts and catering operations. The company was incorporated in 1983 and is based in New York, New York.
Earnings Per Share
As for profitability, Ark Restaurants Corp. has a trailing twelve months EPS of $2.02.
PE Ratio
Ark Restaurants Corp. has a trailing twelve months price to earnings ratio of 8.07. Meaning, the purchaser of the share is investing $8.07 for every dollar of annual earnings.
Volume
Today’s last reported volume for Ark Restaurants Corp. is 5865 which is 56.94% above its average volume of 3737.
Yearly Top and Bottom Value
Ark Restaurants Corp.’s stock is valued at $16.31 at 02:23 EST, way under its 52-week high of $21.43 and higher than its 52-week low of $15.50.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Ark Restaurants Corp.’s EBITDA is 0.81.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
